We would love to hear your thoughts about our site and services, please take our survey here.
Shins that's a good point. I guess one's instinct is to give to those who are admitted, as chances are there's already a degree of breathlessness. Then one could argue a monitoring of breathlessness before hospital admission so that SNG001 could prevent admission and associated costs. At the end of the day, it's likely that a cost/benefit analysis might drive the protocol.
He really does seem to live up to his name, doesn't he?! I am following the science, following the interferons, following the immune response. Patience, ye all:)
I think professional investors are generally extremely risk averse. They don't want to sit back with their money sitting quietly in something even though the medium to long term has excellent chances of multibagging. Their money will be catching other sure thing returns. Then, when the news is out, they'll probably enter at £3-5 for slam dunk returns. Let's just be patient, we're coming around the final bend :)
Everything about SNG001 and its action makes sense to me. The drug works to effectively boost the immune response, seemingly because of the role that the body's interferons have in that response. If we could easily determine those whose immune response level is compromised beyond age, diabetes etc, then we could choose those people to treat early in their infection story. However, breathlessness seems to be the only measurement available at this stage that indicates a compromised immune response, hence SNG001 's success in these patients. The logic of this is the reason that I remain invested, as well as the fact that it is not just a Covid treatment.:)
So Manc, which RNS was that? Nice paid de-ramp effort. Please scuttle off somewhere where you know what you're talking about.
No gloating, we investors have all taken a risk with our money however confident we are in the final outcome. Just interested to know how much that poster was paid......
Fair enough, though I do have spme humble pie in the fridge that 8s going begging!
Just wondering, what has happened to the famous 'Interferonologist' who worked in interferons in Roman times?:)
I wouldn't bother with emailing the press, they're useless. They only wake up when the word 'Oxford' is used. Maybe Synairgen could have an empty office space in Oxford, to work around the handicap! Mind you, probably not worth associating with that place.
Totally agree Ndn - Odds schmodds!!
I'd love to ask Holgate, Marsden et al their opinion on the risk profile. All this effort, all this success up until now, all this preparation for the future is enough for me to consider my investment risk to now be pretty low. Institutional investors rarely get involved at this stage. Their risk profile is more algorithm based, not looking to multi-bag like we are.
Sakura, are you serious? Have you been following the Synairgen story, rhetoric and results so far? Best you do some research
'Arise Lord Holgate, thank you for knowing it works!' :)
Sloane, your post is so well-informed. You show such knowledge about Synairgen and the applications of its drug. How much do you get paid for such drivel?
I confess to not knowing anything about the hidden plans of the likes of Polygon. However, I rest easy in the fact that
1.SNG has been derisked considerably following the recent Activ2 - 3 news
2. The company leadership is excellent and wants to maximise the return for the shareholders, be it with a takeover or a licensing deal
3. The treatment makes sense, is agnostic, has long term non covid applications
4. The likes of Polygon are likely to want their pound of flesh and also get maximum shareholder return like us.
Am I naiive? Holding very strong and amazed at the lack of media coverage, they really are either useless, lazy or both! Well done to the Daily Express, not my usual read :)
Bruce, please read my post again. I'm not saying that SNG001 is a pill. I said that it affects the viral response in the tissues that need it ie the lungs ie nubulised :)
Oh, don't the press love a good pill as a solution!! As medically trained, it was always a given that pills don't really treat a virus, so I'm a little sceptical. The timeline also seems fast - what trial phase are they in, and what is the recorded success so far? The beauty of Synairgen's gift to the world is that is affects the viral response in the tissues that need it.
Ooh, please let me get into this price prediction business!
Majorly derisked now - 195 low
Gradual build up up until Christmas - 350
Activ 2 results come through with EUA application - 500
Sprinter results in New Year - 650 - 750
Takeover May 22 - 4billion plus (£20)
One can dream! ;)
At the end of the day Polygon are in it for the money. They don't want to buy a pharma company. They have done their research well, like us, and can see the huge potential which has now been derisked further. They've got lots of shares still on the cheap, before the institutional sheep come on board and before a big pharma comes knocking. BTW, 4 billion is peanuts to these guys, and a highly likely takeover minimum
Look up polygoninv.com
Investment fund
All looking great. As my friend told me this morning, institutional investors are like sheep. They don't really do high risk, which they see this as at the moment. Their loss! Have topped up this morning. Good investor research with basic scientific knowledge and recognition of great company scientists and leadership has, in my opinion, taken this share down to medium/low risk, as Polygon already knows. Personally won't start cashing in before £20 per share, equivalent to £4 billion market cap.